Literature DB >> 34614176

Impaired Muscle Mitochondrial Function in Familial Partial Lipodystrophy.

Vinaya Simha1, Ian R Lanza1, Surendra Dasari2, Katherine A Klaus1, Nathan Le Brasseur3, Ivan Vuckovic4, Marcello C Laurenti5, Claudio Cobelli5, John D Port6, K Sreekumaran Nair1.   

Abstract

CONTEXT: Familial partial lipodystrophy (FPL), Dunnigan variety is characterized by skeletal muscle hypertrophy and insulin resistance besides fat loss from the extremities. The cause for the muscle hypertrophy and its functional consequences is not known.
OBJECTIVE: To compare muscle strength and endurance, besides muscle protein synthesis rate between subjects with FPL and matched controls (n = 6 in each group). In addition, we studied skeletal muscle mitochondrial function and gene expression pattern to help understand the mechanisms for the observed differences.
METHODS: Body composition by dual-energy X-ray absorptiometry, insulin sensitivity by minimal modelling, assessment of peak muscle strength and fatigue, skeletal muscle biopsy and calculation of muscle protein synthesis rate, mitochondrial respirometry, skeletal muscle transcriptome, proteome, and gene set enrichment analysis.
RESULTS: Despite increased muscularity, FPL subjects did not demonstrate increased muscle strength but had earlier fatigue on chest press exercise. Decreased mitochondrial state 3 respiration in the presence of fatty acid substrate was noted, concurrent to elevated muscle lactate and decreased long-chain acylcarnitine. Based on gene transcriptome, there was significant downregulation of many critical metabolic pathways involved in mitochondrial biogenesis and function. Moreover, the overall pattern of gene expression was indicative of accelerated aging in FPL subjects. A lower muscle protein synthesis and downregulation of gene transcripts involved in muscle protein catabolism was observed.
CONCLUSION: Increased muscularity in FPL is not due to increased muscle protein synthesis and is likely due to reduced muscle protein degradation. Impaired mitochondrial function and altered gene expression likely explain the metabolic abnormalities and skeletal muscle dysfunction in FPL subjects.
© The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  insulin resistance; lipodystrophy; mitochondria; skeletal muscle hypertrophy

Mesh:

Year:  2022        PMID: 34614176      PMCID: PMC8764358          DOI: 10.1210/clinem/dgab725

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   6.134


  68 in total

1.  Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice.

Authors:  O Gavrilova; B Marcus-Samuels; D Graham; J K Kim; G I Shulman; A L Castle; C Vinson; M Eckhaus; M L Reitman
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

2.  Oral glucose tolerance test minimal model indexes of beta-cell function and insulin sensitivity.

Authors:  E Breda; M K Cavaghan; G Toffolo; K S Polonsky; C Cobelli
Journal:  Diabetes       Date:  2001-01       Impact factor: 9.461

3.  Skeletal muscle morphology and exercise response in congenital generalized lipodystrophy.

Authors:  A Garg; J Stray-Gundersen; D Parsons; L A Bertocci
Journal:  Diabetes Care       Date:  2000-10       Impact factor: 19.112

4.  Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member.

Authors:  A C McPherron; A M Lawler; S J Lee
Journal:  Nature       Date:  1997-05-01       Impact factor: 49.962

Review 5.  Acquired and inherited lipodystrophies.

Authors:  Abhimanyu Garg
Journal:  N Engl J Med       Date:  2004-03-18       Impact factor: 91.245

6.  Antagonistic functions of LMNA isoforms in energy expenditure and lifespan.

Authors:  Isabel C Lopez-Mejia; Marion de Toledo; Carine Chavey; Laure Lapasset; Patricia Cavelier; Celia Lopez-Herrera; Karim Chebli; Philippe Fort; Guillaume Beranger; Lluis Fajas; Ez Z Amri; Francois Casas; Jamal Tazi
Journal:  EMBO Rep       Date:  2014-03-17       Impact factor: 8.807

Review 7.  Impact of mitochondrial toxicity of HIV-1 antiretroviral drugs on lipodystrophy and metabolic dysregulation.

Authors:  Eoin R Feeney; Patrick W G Mallon
Journal:  Curr Pharm Des       Date:  2010-10       Impact factor: 3.116

8.  Effect of age on in vivo rates of mitochondrial protein synthesis in human skeletal muscle.

Authors:  O E Rooyackers; D B Adey; P A Ades; K S Nair
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

9.  Synthesis rate of muscle proteins, muscle functions, and amino acid kinetics in type 2 diabetes.

Authors:  Panagiotis Halvatsiotis; Kevin R Short; Maureen Bigelow; K Sreekumaran Nair
Journal:  Diabetes       Date:  2002-08       Impact factor: 9.461

10.  Seipin regulates lipid homeostasis by ensuring calcium-dependent mitochondrial metabolism.

Authors:  Long Ding; Xiao Yang; He Tian; Jingjing Liang; Fengxia Zhang; Guodong Wang; Yingchun Wang; Mei Ding; Guanghou Shui; Xun Huang
Journal:  EMBO J       Date:  2018-07-26       Impact factor: 11.598

View more
  2 in total

1.  Approach to the Patient With Lipodystrophy.

Authors:  Lindsay T Fourman; Steven K Grinspoon
Journal:  J Clin Endocrinol Metab       Date:  2022-05-17       Impact factor: 6.134

2.  Leptin mediates the regulation of muscle mass and strength by adipose tissue.

Authors:  Kelsey H Collins; Chang Gui; Erica V Ely; Kristin L Lenz; Charles A Harris; Farshid Guilak; Gretchen A Meyer
Journal:  J Physiol       Date:  2022-08-02       Impact factor: 6.228

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.